Segment Transport Versus Acute Shortening In The Treatment of Tibial Pseudarthroses With Bone Loss

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01246934

Enrollment

Registered

2010-11-24

Start date

2009-10-31

Completion date

2010-02-28

Last updated

2010-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TIBIA PSEUDOARTHROSES

Brief summary

In this study the investigators are presenting the advantages as well as the disadvantages of ACUTE SHORTENING AND RELENGTHENINIG VS SEGMENT TRANSPORT methods.

Interventions

OTHERASR METHOD

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

13 Years to 50 Years

Inclusion criteria

TIBIA PSEUDOARTHROSES -

Exclusion criteria

BONE LOSS GREATER THAN 10 CM \-

Design outcomes

Primary

Measure	Time frame
TREATMENT PERIOD AND COMPLICATION RATE	—

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026